Bird Flu is Back in China: URMC Testing Vaccine Candidate

ChickensThis month, China confirmed two new cases of H7N9 bird flu – the first reports since August. Estimates put the total number of laboratory-confirmed human cases of H7N9 infection at 136 and the total number of deaths at 45. URMC’s Chief of Infectious Diseases John Treanor, M.D. says that no cases of H7N9 have been identified in the U.S., but the Centers for Disease Control is still following the situation closely and taking precautionary action, developing a vaccine candidate in case it is needed in the face of a pandemic.

Treanor, who heads the University’s Vaccine Research Unit and has helped lead the nation’s response to several infectious threats, is testing this live-virus vaccine candidate in an isolation-style study this fall. The project will test two different schedules of nasal vaccine and boosters, hoping to shed light on which approach does a better job priming the immune system against H7N9. The research is funded by the National Institutes of Health, using experimental vaccines manufactured by MedImmune (makers of seasonal FluMist®) and Sanofi.

Emily Boynton | 10/31/2013 | 1 comment

Comments

Comments
Barbara Mahoney-Walker
I would like to note that this study is still happening. The study is still in need of volunteers for the next isolation dated 12/2/2013.
11/7/2013 11:41:16 AM
 
Leave a comment



 Security code

About The Blog

The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.

Follow @URMCResearch

Though health advice offered here is provided by experts, there is no substitute for the personal care your own provider can offer. If you have medical questions or concerns, please contact your physician.


Blog posts